BDBM50313826 (+/-)-5-(1,1-Dioxo-1,3-dihydro-1lambda*6*-benzo[d]isothiazol-2-ylmethyl)-5-(4-fluoro-phenyl)-imidazolidine-2,4-dione::CHEMBL1087930
SMILES: Fc1ccc(cc1)C1(CN2Cc3ccccc3S2(=O)=O)NC(=O)NC1=O
InChI Key: InChIKey=NCEBBHOMOAWRPQ-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Disintegrin and metalloproteinase domain-containing protein 17 (Homo sapiens (Human)) | BDBM50313826 ((+/-)-5-(1,1-Dioxo-1,3-dihydro-1lambda*6*-benzo[d]...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | 1.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of TACE by FRET assay | Bioorg Med Chem Lett 20: 1877-80 (2010) Article DOI: 10.1016/j.bmcl.2010.01.148 BindingDB Entry DOI: 10.7270/Q2F76CQ9 | |||||||||||
More data for this Ligand-Target Pair |